Cargando…
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
Autores principales: | Araujo, Angela M., Abaurrea, Andrea, Azcoaga, Peio, López-Velazco, Joanna I., Manzano, Sara, Rodriguez, Javier, Rezola, Ricardo, Egia-Mendikute, Leire, Valdés-Mora, Fátima, Flores, Juana M., Jenkins, Liam, Pulido, Laura, Osorio-Querejeta, Iñaki, Fernández-Nogueira, Patricia, Ferrari, Nicola, Viera, Cristina, Martín-Martín, Natalia, Tzankov, Alexandar, Eppenberger-Castori, Serenella, Alvarez-Lopez, Isabel, Urruticoechea, Ander, Bragado, Paloma, Coleman, Nicholas, Palazón, Asís, Carracedo, Arkaitz, Gallego-Ortega, David, Calvo, Fernando, Isacke, Clare M., Caffarel, María M., Lawrie, Charles H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525111/ https://www.ncbi.nlm.nih.gov/pubmed/36169029 http://dx.doi.org/10.1172/JCI165107 |
Ejemplares similares
-
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
por: Araujo, Angela M., et al.
Publicado: (2022) -
New perspectives in cancer immunotherapy: targeting IL-6 cytokine family
por: Soler, Maria Florencia, et al.
Publicado: (2023) -
Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature
por: Serna, Leyre, et al.
Publicado: (2023) -
Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma
por: Caffarel, Maria M, et al.
Publicado: (2014) -
Increased Level of Phosphorylated ShcA Measured by Chemiluminescence-Linked Immunoassay Is a Predictor of Good Prognosis in Primary Breast Cancer Expressing Low Levels of Estrogen Receptor
por: Cicenas, Jonas, et al.
Publicado: (2010)